• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment.

作者信息

Siveke Jens T

机构信息

Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany; and German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany

出版信息

J Nucl Med. 2018 Sep;59(9):1412-1414. doi: 10.2967/jnumed.118.214361. Epub 2018 Aug 10.

DOI:10.2967/jnumed.118.214361
PMID:30097504
Abstract
摘要

相似文献

1
Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment.成纤维细胞激活蛋白：靶向肿瘤微环境的根源
J Nucl Med. 2018 Sep;59(9):1412-1414. doi: 10.2967/jnumed.118.214361. Epub 2018 Aug 10.
2
Cancer-Targeting Functionalization of Selenium-Containing Ruthenium Conjugate with Tumor Microenvironment-Responsive Property to Enhance Theranostic Effects.具有肿瘤微环境响应特性的含硒钌共轭物的癌症靶向功能化以增强诊疗效果。
Chemistry. 2018 Mar 2;24(13):3289-3298. doi: 10.1002/chem.201705561. Epub 2018 Feb 5.
3
Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.肿瘤相关巨噬细胞、纳米医学与成像：癌症免疫治疗未来的成功轴心
Immunotherapy. 2017 Sep;9(10):819-835. doi: 10.2217/imt-2017-0041.
4
Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.用于癌症诊疗的靶向和重塑肿瘤微环境的纳米颗粒
J Biomed Nanotechnol. 2018 Jul 1;14(7):1189-1207. doi: 10.1166/jbn.2018.2546.
5
Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.基于 2,3-二苯基苯并[g]喹喔啉的近红外发射杂环阳离子铱配合物作为体外诊断与治疗的光动力治疗试剂。
Dalton Trans. 2017 Jun 27;46(25):8091-8103. doi: 10.1039/c7dt00913e.
6
Targeted nanotechnologies for cancer intervention: a patent review (2010-2016).用于癌症干预的靶向纳米技术：专利综述（2010 - 2016年）
Expert Opin Ther Pat. 2017 Sep;27(9):1005-1019. doi: 10.1080/13543776.2017.1344216. Epub 2017 Jun 22.
7
Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model.靶向成纤维细胞活化蛋白的基质细胞免疫接种为乳腺癌小鼠模型提供免疫治疗。
Tumour Biol. 2016 Aug;37(8):10317-27. doi: 10.1007/s13277-016-4825-4. Epub 2016 Feb 3.
8
Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.新兴纳米疗法重塑肿瘤微环境。
Trends Pharmacol Sci. 2018 Jan;39(1):59-74. doi: 10.1016/j.tips.2017.10.009. Epub 2017 Nov 15.
9
Theranostic 2D ultrathin MnO nanosheets with fast responsibility to endogenous tumor microenvironment and exogenous NIR irradiation.具有快速响应内源性肿瘤微环境和外源性近红外辐射功能的治疗诊断学 2D 超薄 MnO 纳米片。
Biomaterials. 2018 Feb;155:54-63. doi: 10.1016/j.biomaterials.2017.11.015. Epub 2017 Nov 14.
10
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.免疫结构、免疫评分和恶性细胞分子亚群在癌症预后和治疗分类中的应用。
Adv Immunol. 2016;130:95-190. doi: 10.1016/bs.ai.2015.12.002. Epub 2016 Jan 29.

引用本文的文献

1
Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypes.FAP作为广泛胆管癌亚型潜在治疗诊断靶点的免疫组化基础。
Front Nucl Med. 2024 Nov 27;4:1480471. doi: 10.3389/fnume.2024.1480471. eCollection 2024.
2
Harnessing the Potential of FAP-IL12mut TMEkine for Targeted and Enhanced Antitumor Responses.利用FAP-IL12mut TMEkine的潜力实现靶向性增强抗肿瘤反应。
Mol Cancer Ther. 2025 Feb 4;24(2):176-187. doi: 10.1158/1535-7163.MCT-24-0125.
3
Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review.
新兴生物标志物在非小细胞肺癌治疗中的识别与应用：系统评价
Cancers (Basel). 2024 Jun 26;16(13):2338. doi: 10.3390/cancers16132338.
4
The Immune Response of Cancer Cells in Breast and Gynecologic Neoplasms.乳腺癌和妇科肿瘤中的癌细胞免疫反应。
Int J Mol Sci. 2024 Jun 5;25(11):6206. doi: 10.3390/ijms25116206.
5
PET/MRI and Novel Targets for Breast Cancer.正电子发射断层显像/磁共振成像与乳腺癌的新型靶点
Biomedicines. 2024 Jan 12;12(1):172. doi: 10.3390/biomedicines12010172.
6
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.镓-68 标记的成纤维细胞激活蛋白抑制剂-46 PET 在可切除或交界可切除胰腺导管腺癌患者中的应用：一项 2 期、多中心、单臂、开放标签、非随机研究方案。
PLoS One. 2023 Nov 27;18(11):e0294564. doi: 10.1371/journal.pone.0294564. eCollection 2023.
7
Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study.FAPI-PET/CT在检查多种恶性肿瘤方面的优势：一项回顾性研究。
Am J Cancer Res. 2023 Oct 15;13(10):4547-4559. eCollection 2023.
8
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on F-FDG.正电子发射断层扫描/计算机断层扫描（PET/CT）在结直肠癌肝转移评估中的应用：一项全面综述，重点关注 F-FDG。
Clin Exp Metastasis. 2023 Dec;40(6):465-491. doi: 10.1007/s10585-023-10231-9. Epub 2023 Sep 8.
9
What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature.放射性核素标记 FAPI PET 在乳腺癌中的应用：文献系统综述。
Ann Nucl Med. 2023 Aug;37(8):442-450. doi: 10.1007/s12149-023-01852-x. Epub 2023 Jun 21.
10
The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer.成纤维细胞激活蛋白-α作为一种新型生物标志物在结直肠癌中的预后和治疗价值及其临床意义。
Cell Commun Signal. 2023 Jun 14;21(1):139. doi: 10.1186/s12964-023-01151-y.